Ergoteles’s Octave Specialty Group OSG Stock Holding History

Ergoteles’s Portfolio OSG Stock Details OSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,241	Closed	-$286K	–	1522
2022 Q2	$286K	Sell	25,241 -63,010	-71%	-$598K	0.01%	1128
2022 Q1	$918K	Buy	+88,251	New	+$1.2M	0.03%	459

Other funds holding OSG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ergoteles's OSG Position: Q3 2022 in Review

Ergoteles sold out of Octave Specialty Group (OSG) in Q3 2022, closing a stake of 25,241 shares — an estimated $286K sold.

Ergoteles first reported a position in OSG in Q1 2022 and held it in 2 quarters. The position peaked at $918K in Q1 2022. 154 funds tracked by Wall St. Rank hold OSG as of Q3 2022.

Ergoteles reported no remaining Octave Specialty Group position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 25,241 Octave Specialty Group shares in Q3 2022, an estimated $286K.
Ergoteles first reported a position in Octave Specialty Group in Q1 2022 and held it in 2 quarters.
Ergoteles's Octave Specialty Group position peaked at $918K in Q1 2022.
154 funds tracked by Wall St. Rank held Octave Specialty Group as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.